{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:12:19Z","timestamp":1788433939071,"version":"build-2803163510"},"reference-count":74,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>We conducted a systematic review and meta-analysis of associations between apolipoprotein E (APOE) alleles and frontotemporal lobar degeneration (FTLD)-spectrum disorders. MEDLINE, Embase, CENTRAL, and Google Scholar were searched. APOE2 and APOE4 carrier status were compared between FTLD-spectrum disorders and healthy controls (HCs) or individuals with Alzheimer\u2019s disease (AD). Forty studies were included. APOE4 carriage was more frequent in frontotemporal dementia (FTD) compared with HC (OR = 1.72; 95% CI = 1.45\u20132.04) and less common than in AD (OR = 0.35; 95% CI = 0.29\u20130.42). In contrast, APOE2 carriage was less prevalent in FTD relative to HC (OR = 0.83; 95% CI = 0.70\u20130.98) but more frequent compared with AD (OR = 1.80; 95% CI = 1.29\u20132.52). APOE4 effects were most pronounced in behavioral variant FTD. In clinically confirmed progressive supranuclear palsy (PSP), APOE4 carriage was not associated with PSP. Analysis restricted to pathologically confirmed PSP cases, however, showed lower APOE4 carriage in PSP than in healthy controls (OR = 0.78, 95% CI = 0.65\u20130.94), although this association failed to reach the multiplicity-adjusted significance threshold. APOE2 carriage was not associated with PSP in either clinically established or pathologically confirmed samples. Evidence was insufficient to establish or exclude associations for other FTLD-spectrum disorders because of the limited available data. In conclusion, APOE alleles show distinct associations across the FTLD spectrum.<\/jats:p>","DOI":"10.3390\/ijms27177752","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:48:36Z","timestamp":1788256116000},"page":"7752","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Apolipoprotein E Alleles Across the Spectrum of Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2958-5220","authenticated-orcid":false,"given":"Ioannis","family":"Liampas","sequence":"first","affiliation":[{"name":"Department of Neurology, School of Medicine, University of Thessaly, 41500 Larissa, Greece"},{"name":"Department of Neurology, School of Medicine, University of Patras, 26504 Rio Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8506-4989","authenticated-orcid":false,"given":"Antonis","family":"Polyviou","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Patras, 26504 Rio Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5105-0196","authenticated-orcid":false,"given":"Silvia","family":"Demiri","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Patras, 26504 Rio Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Malataras","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Patras, 26504 Rio Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilis","family":"Oikonomakis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University Hospital of Patras, 26504 Rio Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Siokas","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, University of Thessaly, 41500 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8317-6428","authenticated-orcid":false,"given":"Odysseas","family":"Kargiotis","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, University of Patras, 26504 Rio Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinovia-Maria","family":"Kefalopoulou","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, University of Patras, 26504 Rio Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Chroni","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, University of Patras, 26504 Rio Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2957-641X","authenticated-orcid":false,"given":"Efthimios","family":"Dardiotis","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, University of Thessaly, 41500 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Liampas, I., Kyriakoulopoulou, P., Siokas, V., Tsiamaki, E., Stamati, P., Kefalopoulou, Z., Chroni, E., and Dardiotis, E. (2024). Apolipoprotein E Gene in \u03b1-Synucleinopathies: A Narrative Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031795"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer\u2019s disease: Advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Das","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","article-title":"Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis","volume":"109","author":"Chen","year":"2021","journal-title":"Neuron"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.apsb.2021.10.002","article-title":"Apolipoprotein E and Alzheimer\u2019s disease","volume":"12","author":"Troutwine","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/humu.22080","article-title":"Deep phenotyping for precision medicine","volume":"33","author":"Robinson","year":"2012","journal-title":"Hum. Mutat."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"103433","DOI":"10.1016\/j.jbi.2020.103433","article-title":"Deep phenotyping: Embracing complexity and temporality\u2014Towards scalability, portability, and interoperability","volume":"105","author":"Weng","year":"2020","journal-title":"J. Biomed. Inform."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s13311-023-01380-6","article-title":"New Approaches to the Treatment of Frontotemporal Dementia","volume":"20","author":"Neylan","year":"2023","journal-title":"Neurotherapeutics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1176\/appi.focus.20160018","article-title":"A Clinical Guide to Frontotemporal Dementias","volume":"14","author":"Ljubenkov","year":"2016","journal-title":"Focus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ncl.2017.01.008","article-title":"Frontotemporal Dementia","volume":"35","author":"Olney","year":"2017","journal-title":"Neurol. Clin."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1212\/CON.0000000000000300","article-title":"Frontotemporal Dementias","volume":"22","author":"Finger","year":"2016","journal-title":"Continuum"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/11533100-000000000-00000","article-title":"Frontotemporal Lobar Degeneration: Epidemiology, Pathophysiology, Diagnosis and Management","volume":"24","author":"Rabinovici","year":"2010","journal-title":"CNS Drugs"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2353\/ajpath.2006.060438","article-title":"Pathological Heterogeneity of Frontotemporal Lobar Degeneration with Ubiquitin-Positive Inclusions Delineated by Ubiquitin Immunohistochemistry and Novel Monoclonal Antibodies","volume":"169","author":"Sampathu","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41572-023-00447-0","article-title":"Frontotemporal lobar degeneration","volume":"9","author":"Grossman","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"43721","DOI":"10.18632\/oncotarget.17341","article-title":"Updated meta-analysis of the role of APOE \u03b52\/\u03b53\/\u03b54 alleles in frontotemporal lobar degeneration","volume":"8","author":"Su","year":"2017","journal-title":"Oncotarget"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00401-014-1380-1","article-title":"Frontotemporal lobar degeneration: Defining phenotypic diversity through personalized medicine","volume":"129","author":"Irwin","year":"2015","journal-title":"Acta Neuropathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jalz.2012.10.013","article-title":"Apolipoprotein E polymorphisms in frontotemporal lobar degeneration: A meta-analysis","volume":"9","author":"Rubino","year":"2013","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_17","first-page":"277","article-title":"ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-\u03b2 copathology","volume":"11","author":"Koriath","year":"2019","journal-title":"Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of Observational Studies in EpidemiologyA Proposal for Reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/alz.13740","article-title":"Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study","volume":"20","author":"Sakurai","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Sadhukhan, D., Mishra, S., Mukherjee, P., Biswas, A., Hui, S.P., Banerjee, T.K., and Biswas, A. (2023). Evaluation of. Apolipoprotein e4 allele as susceptible factor for neurodegenerative diseases among Eastern Indians. medRxiv.","DOI":"10.1101\/2023.06.21.23291697"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3233\/JAD-230322","article-title":"Klotho Gene Expression Is Decreased in Peripheral Blood Mononuclear Cells in Patients with Alzheimer\u2019s Disease and Frontotemporal Dementia","volume":"94","author":"Sorrentino","year":"2023","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1515\/tnsci-2020-0098","article-title":"Plasma cholesterol in Alzheimer\u2019s disease and frontotemporal dementia","volume":"11","author":"Wang","year":"2020","journal-title":"Transl. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/awx066","article-title":"Gene-based association studies report genetic links for clinical subtypes of frontotemporal dementia","volume":"140","author":"Mishra","year":"2017","journal-title":"Brain"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/YPG.0000000000000126","article-title":"Associations between APOE polymorphisms and seven diseases with cognitive impairment including Alzheimer\u2019s disease, frontotemporal dementia, and dementia with Lewy bodies in southeast China","volume":"26","author":"Chen","year":"2016","journal-title":"Psychiatr. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3233\/JAD-150746","article-title":"Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias","volume":"50","author":"Vilaplana","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"444.e1","DOI":"10.1016\/j.neurobiolaging.2013.08.011","article-title":"Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer\u2019s disease and frontotemporal dementia","volume":"35","author":"Ruiz","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2012-120379","article-title":"Genetics and Expression Analysis of the Specificity Protein 4 Gene (SP4) in Patients with Alzheimer\u2019s Disease and Frontotemporal Lobar Degeneration","volume":"31","author":"Villa","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000350872","article-title":"Apolipoprotein \u0395 \u03b54 Frequency Is Increased among Chinese Patients with Frontotemporal Dementia and Alzheimer\u2019s Disease","volume":"36","author":"Ji","year":"2013","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3233\/JAD-2011-111541","article-title":"FOXP2, APOE, and PRNP: New Modulators in Primary Progressive Aphasia","volume":"28","author":"Premi","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3233\/JAD-2012-120403","article-title":"TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia","volume":"31","author":"Seripa","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/archneurol.2011.90","article-title":"The APOE Gene Locus in Frontotemporal Dementia and Primary Progressive Aphasia","volume":"68","author":"Seripa","year":"2011","journal-title":"Arch. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/WAD.0b013e318201f249","article-title":"ApoE E4 is a Susceptibility Factor in Amnestic But Not Aphasic Dementias","volume":"25","author":"Rogalski","year":"2011","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_34","first-page":"193","article-title":"APOE \u03b52 and \u03b54 influence the susceptibility for Alzheimer\u2019s disease but not other dementias","volume":"1","author":"Lovati","year":"2010","journal-title":"Int. J. Mol. Epidemiol. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1001\/archneurol.2009.136","article-title":"APOE \u03b52\/\u03b54 Genotype a Risk Factor for Primary Progressive Aphasia in Women","volume":"66","author":"Daniele","year":"2009","journal-title":"Arch. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1073\/pnas.0812697106","article-title":"Apolipoprotein E \u03b54 is associated with disease-specific effects on brain atrophy in Alzheimer\u2019s disease and frontotemporal dementia","volume":"106","author":"Agosta","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JAD-2009-1019","article-title":"MCP-1 A-2518G Polymorphism: Effect on Susceptibility for Frontotemporal Lobar Degeneration and on Cerebrospinal Fluid MCP-1 Levels","volume":"17","author":"Galimberti","year":"2009","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10038-008-0344-5","article-title":"Association study to evaluate the serotonin transporter and apolipoprotein E genes in frontotemporal lobar degeneration in Italy","volume":"53","author":"Albani","year":"2008","journal-title":"J. Hum. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kaivorinne, A.-L., Kr\u00fcger, J., Kuivaniemi, K., Tuominen, H., Moilanen, V., Majamaa, K., and Remes, A.M. (2008). Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland. BMC Neurol., 8.","DOI":"10.1186\/1471-2377-8-48"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1468-1331.2007.02007.x","article-title":"Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration","volume":"15","author":"Venturelli","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/jnnp.2005.063966","article-title":"The apolipoprotein E 4 allele selectively increases the risk of frontotemporal lobar degeneration in males","volume":"77","author":"Srinivasan","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.neurobiolaging.2005.03.008","article-title":"The effects of APOE and tau gene variability on risk of frontotemporal dementia","volume":"27","author":"Bernardi","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1001\/archneur.62.9.1419","article-title":"Association Between Tau H2 Haplotype and Age at Onset in Frontotemporal Dementia","volume":"62","author":"Borroni","year":"2005","journal-title":"Arch. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/jmg.40.11.814","article-title":"Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects","volume":"40","author":"Engelborghs","year":"2003","journal-title":"J. Med. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JAD-2003-5206","article-title":"Apolipoprotein E \u03b54 in an autopsy series of various dementing disorders","volume":"5","author":"Nielsen","year":"2003","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3940(03)00051-X","article-title":"Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer\u2019s disease and frontotemporal dementia","volume":"340","author":"Johansson","year":"2003","journal-title":"Neurosci. Lett."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/jnnp.72.5.639","article-title":"Apolipoprotein E polymorphism in German patients with frontotemporal degeneration","volume":"72","author":"Riemenschneider","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.ejhg.5200820","article-title":"Apolipoprotein E gene in frontotemporal dementia: An association study and meta-analysis","volume":"10","author":"Verpillat","year":"2002","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/exnr.2000.7613","article-title":"Clinic-Based Cases with Frontotemporal Dementia Show Increased Cerebrospinal Fluid Tau and High Apolipoprotein E \u03b54 Frequency, but No Tau Gene Mutations","volume":"168","author":"Forsell","year":"2001","journal-title":"Exp. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000051285","article-title":"Genetic Analysis in Patients with Familial and Sporadic Frontotemporal Dementia: Two Tau Mutations in Only Familial Cases and No Association with Apolipoprotein \u00c24 2001","volume":"12","author":"Kowalska","year":"2001","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13024-024-00747-3","article-title":"Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy","volume":"19","author":"Wang","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/WAD.0000000000000479","article-title":"Role of Apolipoprotein E in the Clinical Profile of Atypical Parkinsonian Syndromes","volume":"36","author":"Nasri","year":"2022","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"105819","DOI":"10.1016\/j.nbd.2022.105819","article-title":"Genetics of progressive supranuclear palsy in a Chinese population","volume":"172","author":"Xiao","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2019.02.016","article-title":"Assessment of APOE in atypical parkinsonism syndromes","volume":"127","author":"Sabir","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1038\/s41467-018-06783-0","article-title":"APOE \u03b52 is associated with increased tau pathology in primary tauopathy","volume":"9","author":"Zhao","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1212\/WNL.55.12.1918","article-title":"Multiple system atrophy\/progressive supranuclear palsy: \u03b1-Synuclein, synphilin, tau, and APOE","volume":"55","author":"Morris","year":"2000","journal-title":"Neurology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.46.4.1156","article-title":"Normal distribution of apolipoprotein E alleles in progressive supranuclear palsy","volume":"46","author":"Anouti","year":"1996","journal-title":"Neurology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/s00406-025-02013-z","article-title":"Plasma biomarkers of amyloid, tau & neuroinflammation in Alzheimer\u2019s disease and corticobasal syndrome","volume":"275","author":"Kurz","year":"2025","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jamaneurol.2015.4773","article-title":"The Role of APOE in the Occurrence of Frontotemporal Dementia in Amyotrophic Lateral Sclerosis","volume":"73","author":"Brunetti","year":"2016","journal-title":"JAMA Neurol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0197-4580(00)00150-0","article-title":"Apolipoprotein E polymorphism in Pick\u2019s disease and in Huntington\u2019s disease","volume":"21","author":"Jakab","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/exnr.1995.1093","article-title":"Allele \u03f54 of Apolipoprotein E Shows a Dose Effect on Age at Onset of Pick Disease","volume":"136","author":"Farrer","year":"1995","journal-title":"Exp. Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: Pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","article-title":"APOE2: Protective mechanism and therapeutic implications for Alzheimer\u2019s disease","volume":"15","author":"Li","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/WAD.0b013e318199dd7d","article-title":"Association Between BDNF Val66Met Polymorphism and Alzheimer Disease, Dementia with Lewy Bodies, and Pick Disease","volume":"23","author":"Janka","year":"2009","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"101594","DOI":"10.1016\/j.smim.2022.101594","article-title":"APOE mediated neuroinflammation and neurodegeneration in Alzheimer\u2019s disease","volume":"59","author":"Parhizkar","year":"2022","journal-title":"Semin. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1590\/S1980-57642013DN70100004","article-title":"Neuropathology of frontotemporal lobar degeneration: A review","volume":"7","author":"Bahia","year":"2013","journal-title":"Dement. Neuropsychol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","article-title":"CNS synaptogenesis promoted by glia-derived cholesterol","volume":"294","author":"Mauch","year":"2001","journal-title":"Science"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","article-title":"APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes","volume":"611","author":"Blanchard","year":"2022","journal-title":"Nature"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng0996-55","article-title":"Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides","volume":"14","author":"Miyata","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"102779","DOI":"10.1016\/j.redox.2023.102779","article-title":"Apolipoprotein E is required for brain iron homeostasis in mice","volume":"64","author":"Ma","year":"2023","journal-title":"Redox Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1084\/jem.20190980","article-title":"Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model","volume":"216","author":"Shi","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.neurobiolaging.2007.12.003","article-title":"APOE-related mortality: Effect of dementia, cardiovascular disease and gender","volume":"30","author":"Rosvall","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Liampas, I., Demiri, S., Siokas, V., Tsika, A., Marogianni, C., Stamati, P., Nasios, G., Messinis, L., Lyketsos, C.G., and Dardiotis, E. (2025). Apolipoprotein E Alleles and Motor Signs in Older Adults with Alzheimer\u2019s Dementia. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202506.1742.v1"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7752\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:12:26Z","timestamp":1788430346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":74,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177752"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177752","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]}}}